113 related articles for article (PubMed ID: 31242188)
1. Identifying small molecule probes of ENTPD5 through high throughput screening.
Durst MA; Ratia K; Lavie A
PLoS One; 2019; 14(6):e0210305. PubMed ID: 31242188
[TBL] [Abstract][Full Text] [Related]
2. ENTPD5-mediated modulation of ATP results in altered metabolism and decreased survival in gliomablastoma multiforme.
Zadran S; Amighi A; Otiniano E; Wong K; Zadran H
Tumour Biol; 2012 Dec; 33(6):2411-21. PubMed ID: 22992974
[TBL] [Abstract][Full Text] [Related]
3. Mutant p53 promotes tumor progression and metastasis by the endoplasmic reticulum UDPase ENTPD5.
Vogiatzi F; Brandt DT; Schneikert J; Fuchs J; Grikscheit K; Wanzel M; Pavlakis E; Charles JP; Timofeev O; Nist A; Mernberger M; Kantelhardt EJ; Siebolts U; Bartel F; Jacob R; Rath A; Moll R; Grosse R; Stiewe T
Proc Natl Acad Sci U S A; 2016 Dec; 113(52):E8433-E8442. PubMed ID: 27956623
[TBL] [Abstract][Full Text] [Related]
4. The ER UDPase ENTPD5 promotes protein N-glycosylation, the Warburg effect, and proliferation in the PTEN pathway.
Fang M; Shen Z; Huang S; Zhao L; Chen S; Mak TW; Wang X
Cell; 2010 Nov; 143(5):711-24. PubMed ID: 21074248
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of ENTPD5 inhibits tumor metastasis and growth via regulating the GRP78/p-eIF-2α/CHOP pathway in serous ovarian cancer.
Chen X; Zha Z; Wang Y; Chen Y; Pang M; Huang L; Chen Y
J Ovarian Res; 2022 Jun; 15(1):69. PubMed ID: 35668504
[TBL] [Abstract][Full Text] [Related]
6. ENTPD5 induces apoptosis in lung cancer cells via regulating caspase 3 expression.
Xue Y; Wu L; Liu Y; Ma Y; Zhang L; Ma X; Yang Y; Chen J
PLoS One; 2015; 10(3):e0120046. PubMed ID: 25794010
[TBL] [Abstract][Full Text] [Related]
7. The UDPase ENTPD5 regulates ER stress-associated renal injury by mediating protein N-glycosylation.
Xu L; Zhou Y; Wang G; Bo L; Jin B; Dai L; Lu Q; Cai X; Hu L; Liu L; Wu Y; Chang X; Huang Y; Song L; Zhang T; Wang Y; Xiao Y; Zhang F; Liu L; Shi M; Wang T; Guo B
Cell Death Dis; 2023 Feb; 14(2):166. PubMed ID: 36849424
[TBL] [Abstract][Full Text] [Related]
8. Ectonucleoside triphosphate diphosphohydrolase type 5 (Entpd5)-deficient mice develop progressive hepatopathy, hepatocellular tumors, and spermatogenic arrest.
Read R; Hansen G; Kramer J; Finch R; Li L; Vogel P
Vet Pathol; 2009 May; 46(3):491-504. PubMed ID: 19176496
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol triggers ER stress-mediated apoptosis by disrupting N-linked glycosylation of proteins in ovarian cancer cells.
Gwak H; Kim S; Dhanasekaran DN; Song YS
Cancer Lett; 2016 Feb; 371(2):347-53. PubMed ID: 26704305
[TBL] [Abstract][Full Text] [Related]
10. ENTPD5, an endoplasmic reticulum UDPase, alleviates ER stress induced by protein overloading in AKT-activated cancer cells.
Shen Z; Huang S; Fang M; Wang X
Cold Spring Harb Symp Quant Biol; 2011; 76():217-23. PubMed ID: 22169232
[TBL] [Abstract][Full Text] [Related]
11. High-throughput cell-based screening of 4910 known drugs and drug-like small molecules identifies disulfiram as an inhibitor of prostate cancer cell growth.
Iljin K; Ketola K; Vainio P; Halonen P; Kohonen P; Fey V; Grafström RC; Perälä M; Kallioniemi O
Clin Cancer Res; 2009 Oct; 15(19):6070-8. PubMed ID: 19789329
[TBL] [Abstract][Full Text] [Related]
12. The ENTPD5/mt-PCPH oncoprotein is a catalytically inactive member of the ectonucleoside triphosphate diphosphohydrolase family.
MacCarthy CM; Notario V
Int J Oncol; 2013 Oct; 43(4):1244-52. PubMed ID: 23921441
[TBL] [Abstract][Full Text] [Related]
13. p53 gain-of-function mutations promote metastasis via ENTPD5 upregulation and enhanced N-glycoprotein folding.
Timofeev O; Stiewe T
Mol Cell Oncol; 2017; 4(2):e1288678. PubMed ID: 28401189
[TBL] [Abstract][Full Text] [Related]
14. --A high-throughput screen identifies inhibitors of the interaction between the oncogenic transcription factor ERG and the cofactor EWS.
Nicholas TR; Meng J; Greulich BM; Morris TS; Hollenhorst PC
PLoS One; 2020; 15(9):e0238999. PubMed ID: 32915889
[TBL] [Abstract][Full Text] [Related]
15. Development of a 3D Tissue Culture-Based High-Content Screening Platform That Uses Phenotypic Profiling to Discriminate Selective Inhibitors of Receptor Tyrosine Kinases.
Booij TH; Klop MJ; Yan K; Szántai-Kis C; Szokol B; Orfi L; van de Water B; Keri G; Price LS
J Biomol Screen; 2016 Oct; 21(9):912-22. PubMed ID: 27412535
[TBL] [Abstract][Full Text] [Related]
16. High-Content Screening Campaign to Identify Compounds That Inhibit or Disrupt Androgen Receptor-Transcriptional Intermediary Factor 2 Protein-Protein Interactions for the Treatment of Prostate Cancer.
Fancher AT; Hua Y; Camarco DP; Close DA; Strock CJ; Johnston PA
Assay Drug Dev Technol; 2018; 16(6):297-319. PubMed ID: 30109944
[TBL] [Abstract][Full Text] [Related]
17. Identity between the PCPH proto-oncogene and the CD39L4 (ENTPD5) ectonucleoside triphosphate diphosphohydrolase gene.
Páez JG; Recio JA; Rouzaut A; Notario V
Int J Oncol; 2001 Dec; 19(6):1249-54. PubMed ID: 11713596
[TBL] [Abstract][Full Text] [Related]
18. Screen Targeting Lung and Prostate Cancer Oncogene Identifies Novel Inhibitors of RGS17 and Problematic Chemical Substructures.
Bodle CR; Schamp JH; O'Brien JB; Hayes MP; Wu M; Doorn JA; Roman DL
SLAS Discov; 2018 Apr; 23(4):363-374. PubMed ID: 29351497
[TBL] [Abstract][Full Text] [Related]
19. Targeting the Type II Secretion System: Development, Optimization, and Validation of a High-Throughput Screen for the Identification of Small Molecule Inhibitors.
Waack U; Johnson TL; Chedid K; Xi C; Simmons LA; Mobley HLT; Sandkvist M
Front Cell Infect Microbiol; 2017; 7():380. PubMed ID: 28894700
[TBL] [Abstract][Full Text] [Related]
20. High-Content Screening Identifies Src Family Kinases as Potential Regulators of AR-V7 Expression and Androgen-Independent Cell Growth.
Szafran AT; Stephan C; Bolt M; Mancini MG; Marcelli M; Mancini MA
Prostate; 2017 Jan; 77(1):82-93. PubMed ID: 27699828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
